Předmět: |
|
Zdroj: |
Clinical Cardiology Alert; Dec2024, Vol. 43 Issue 12, p1-14, 14p |
Abstrakt: |
The article focuses on the benefits of aggressive early cholesterol-lowering after myocardial infarction (MI) compared to the traditional stepwise approach. Topics include the impact of achieving non-high-density lipoprotein cholesterol (nHDL-C) targets within two months, the association of sustained nHDL-C reduction with reduced major adverse cardiac events (MACE), and the challenges to current post-MI cholesterol management guidelines. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|